NCT06632730
- Conditions
- Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +10 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
Clinical trial condition
Explore clinical trials studying Spinal Muscular Atrophy Type II. Study availability and eligibility vary by location and protocol.
NCT06632730
NCT05715749
NCT05416034
NCT01302600
NCT06300996
NCT04042025
NCT03709784